🇺🇸 FDA
Patent

US 7361646

Methods for treating gastroesophageal reflux disease

granted A61KA61K31/00A61K31/56

Quick answer

US patent 7361646 (Methods for treating gastroesophageal reflux disease) held by Corcept Therapeutics Incorporated expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/00, A61K31/56, A61K31/573, A61K31/59